Streetbeat News

Equity Actions

AVGO

34 analysts have recently updated their ratings on Broadcom (NASDAQ:AVGO), showing a diverse range of opinions from bullish to bearish. The average 12-month price target for AVGO has increased by 14.88% to $1553.29. Analyst actions include various adjustments to ratings and price targets, reflecting a positive sentiment overall. Broadcom's financials indicate strong revenue growth and net margin, but challenges in asset utilization and debt management.

Portfolio Pulse from Benzinga Insights

May 13, 2024 | 3:01 pm

MA

The article provides a comparative analysis of Mastercard (NYSE:MA) and its competitors in the Financial Services industry, focusing on key financial metrics such as P/E, P/B, P/S ratios, ROE, EBITDA, gross profit, and revenue growth. Mastercard is highlighted for its potential growth, operational efficiency, and profitability, despite concerns about its valuation and slower revenue growth compared to the industry average.

Portfolio Pulse from Benzinga Insights

May 13, 2024 | 3:00 pm

ATO

Atmos Energy (NYSE:ATO) received varied analyst ratings in the last quarter, with an average 12-month price target of $128.25, indicating a 4.27% increase from the previous target. The company, a leading natural gas utility in the U.S., shows strong revenue growth and net margin but below-average ROE and ROA. Analysts from Mizuho, Wells Fargo, UBS, and Barclays adjusted their ratings and price targets, reflecting optimism about the company's financial health and market position.

Portfolio Pulse from Benzinga Insights

May 13, 2024 | 3:00 pm

TSLA

The analysis compares Tesla (TSLA) against its competitors in the Automobiles industry, focusing on financial metrics like P/E, P/B, P/S ratios, ROE, EBITDA, gross profit, and revenue growth. Tesla's metrics suggest it is trading at a premium with higher P/E, P/B, and P/S ratios but shows potential inefficiency with lower ROE, EBITDA, gross profit, and negative revenue growth compared to industry averages.

Portfolio Pulse from Benzinga Insights

May 13, 2024 | 3:00 pm

BANC

Analyst ratings for Banc of California (NYSE:BANC) show a mix of bullish and bearish perspectives with recent adjustments in price targets and ratings. The average 12-month price target is now $16.2, slightly lower than the previous $16.29. Analysts from firms like Stephens & Co., Piper Sandler, Truist Securities, Barclays, Wedbush, Wells Fargo, and Keefe, Bruyette & Woods have made various adjustments, reflecting a nuanced view of the bank's prospects. Banc of California's financial performance indicates solid revenue growth but challenges in profitability, asset utilization, and high debt levels.

Portfolio Pulse from Benzinga Insights

May 13, 2024 | 3:00 pm

MSFT

The article provides an in-depth analysis of Microsoft (MSFT) against its competitors in the Software industry, focusing on key financial metrics such as P/E, P/B, P/S ratios, ROE, EBITDA, gross profit, and revenue growth. Microsoft is highlighted for its potential growth, profitability, and strong market position, with comparisons to industry averages and top peers.

Portfolio Pulse from Benzinga Insights

May 13, 2024 | 3:00 pm

GGL

Games Global Limited (NYSE:GGL) is set to IPO on May 14, offering shares between $16.00 and $19.00 with a 180-day insider lock-up period ending on November 10, 2024. The company is a leading developer and marketer of online casino-style gaming content.

Portfolio Pulse from Benzinga Insights

May 13, 2024 | 3:00 pm

RNAZ

TransCode Therapeutics (NASDAQ:RNAZ) has issued an open letter to shareholders, requesting authorization for a potential reverse stock split as a last resort to avoid delisting from the Nasdaq Capital Market. The company believes this measure, along with other reasons presented to the Nasdaq Panel, represents their best chance to remain listed. However, there is no assurance that this action will prevent delisting.

Portfolio Pulse from Benzinga Newsdesk

May 13, 2024 | 2:54 pm

SFIX

A significant option activity was observed for Stitch Fix (SFIX) with a sweep of 2364 contracts for June 21 $3 calls near the ask price of $0.15, compared to an open interest of 2369. This activity comes ahead of the company's estimated earnings report on June 4, after the market closes. The reference stock price at the time of the option activity was $2.455.

Portfolio Pulse from Charles Gross

May 13, 2024 | 2:48 pm

CNTX

Avidity Partners Management LP has reported a 9.9% stake in Context Therapeutics as of May 2, 2024, according to a 13G filing with the SEC.

Portfolio Pulse from Benzinga Newsdesk

May 13, 2024 | 2:43 pm